2/27/07
KABA: Area Remains Diverse - Report Shows County Faces Challenges in Poverty, Jobs
A new Kenosha Area Business Alliance report paints Kenosha County as an everchanging, economically diverse area that will continue to see more growth in the future. The report also shows the county's challenges, like a growing... Read Entire Story

2/26/07
Town Hall Meeting with U.S. Secretary of Health and Human Services Michael Leavitt
The Business Health Care Group and the Wisconsin Collaborative for Healthcare Quality invite you to a Town Hall Meeting with United States Secretary of Health and Human Services Michael Leavitt. Please join Secretary... Read Entire Story

2/3/07
Ryan Discusses Health Care - Congressman Tells Business Leaders Cost Still a Challenge
Health care is one of America's most challenging issues, U.S. Rep. Paul Ryan told an audience of Kenosha County business leaders Friday. Ryan, R-Janesville, was the moderator for a Kenosha Area Business Alliance luncheon at... Read Entire Story

2/2/07
More in store - Additional development coming to Highway 50 and I-94
The intersection of Highway 50 and I-94 in Kenosha County is poised to attract major new development in 2007. At the northwest corner of the intersection, Quality Centers, a Florida-based developer, is planning a large... Read Entire Story

2/2/07
KABA Keys Issues Luncheon Focuses on Rising Health Care Costs
Kenosha County is part of one of the fastest-growing metropolitan regions in the United States, its population climbing with the continuing expansion of the greater Chicago area. According to the U.S. Census Bureau, the Chicago includes... Read Entire Story

2/2/07
Snap-on Profits, Revenues Surge
Kenosha-based Snap-on Inc. said Thursday its fourth-quarter profit rose 39 percent, with sales revenue growing in all segments of the business. The company earned $38 million, or 64 cents per share, compared with $27.4 million... Read Entire Story

2/2/07
Hospira Completes its Acquisition of Mayne Pharma Ltd.
Hospital products company Hospira Inc. said Thursday it completed its $2.1 billion buyout of Australia-based specialty injectable pharmaceuticals company Mayne Pharma Ltd. The deal was cleared to close Jan. 19, when... Read Entire Story